October 2008
Worldwide Biotech;Oct2008, Vol. 20 Issue 10, p2
Trade Publication
The article reports that Debiopharm Group has signed on a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification. The research project is expected to lead to the development of potential therapeutic compounds and the identification of new targets to fight cancer stem cells.


Related Articles

  • Lake flights to explore water/air interface.  // Imaging & Machine Vision Europe;Feb/Mar2013, Issue 55, p5 

    The article focuses on the sensor-packed aircraft designed to analyze the water-air interface that will be featured at the exploration programme sponsored by the federal educational institute Ecole Polytechnique Federale de Lausanne.

  • Bubble tracking could lower solar-concentrator cost.  // Laser Focus World;Nov2012, Vol. 48 Issue 11, p10 

    The article offers information on the study conducted by the researchers at the École Polytechnique Fédérale de Lausanne in Switzerland regarding the development of an optofluidic waveguide to form a vapor bubble that scatters the incoming sunlight into the waveguide.

  • Materials science: Illusions to foil counterfeiters.  // Nature;7/25/2013, Vol. 499 Issue 7459, p383 

    The article offers information on a research done by Jürgen Brugger and Victor Cadarso at the Swiss Federal Institute of Technology in Lausanne, Switzerland related to production of fabricated microscopic lines in rows or spirals.

  • Making the paper: Joerg Huelsken. Huelsken, Joerg // Nature;4/3/2008, Vol. 452 Issue 7187, pxiii 

    The article highlights the research of professor Joerg Huelsken and his colleagues from the Swiss Federal Institute of Technology (EPFL) in Lausanne, Switzerland about the role of genetic labeling for hair follicle stem cells in skin cancer. The study showed that stem cells have the potential...

  • Ecole Polytechnique Fédérale de Lausanne Tweaking a gene makes muscles twice as strong.  // Biomedical Market Newsletter;11/14/2011, Vol. 21, p760 

    The article reports on the study conducted by Ecole Polytechnique Fédérale de Lausanne (EPFL) researchers on gene tweaking to make muscles twice as strong than normal in Switzerland. It notes the researchers' creation of super strong, marathon mice by lessening natural inhibitor function....

  • Most robots move slower. Investor's Business Daily // Investors Business Daily;5/14/2014, pA02 

    Most robots move slower than people. But a robotic arm developed at the Swiss Federal Institute of Technology is capable of spotting and catching flying objects in less than five-hundredths of a second. The robotic arm has 3 joints and a 4-fingered hand. One possible application, the scientists...

  • Neuroprosthetics and robots wake up the spinal brain. Kimball, Robert // Medical Device Daily;6/11/2012, Vol. 16 Issue 110, Special section p1 

    The article reports on a study by the researchers at École Polytechnique Fédérale de Lausanne (EPFL) in Lausanne, Switzerland on spinal cord injuries. It says that the study lead author was Grégoire Courtine, wherein severed action of spinal cord can recover when regenerative...

  • The underhand ape. Spinney, Laura // New Scientist;11/5/2011, Vol. 212 Issue 2837, p42 

    The article discusses corruption in humans. She argues that no individual is immune from dishonesty, but understanding the nature of dishonesty may help to prevent it. Topics include the societal impact of dishonesty, results of research by Samuel Bendahan and colleagues at the Swiss Federal...

  • Computer modelling: Brain in a box. Waldrop, M. Mitchell // Nature;2/23/2012, Vol. 482 Issue 7386, p456 

    The article reports on the controversial proposal of brain electrophysiologist Henry Markram of the Swiss Federal Institute of Technology in Lausanne (EPFL) in Switzerland for the Human Brain Project in 2012. It mentions that the project aims to build a supercomputer simulation that incorporates...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics